EGCG promotes apoptosis in cancer cells through various mechanisms, including the inhibition of the Epidermal Growth Factor receptor (EGFR) [78], the activation of caspase (specifically, caspase 9, 8, and 3), and the upregulation of pro-apoptotic proteins such as Bax. This evidence concerns the gene CASP9 and cancer.